Evidence map›Paper›PMID 34989943›Full record

ArticleMetabolic brain disease2022

A novel antagonist of TRPM2 and TRPV4 channels: Carvacrol.

Mustafa Nazıroğlu

Abstract read
In one paragraph

Article in Metabolic brain disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Curcumin protects against MPPMolecular biology reports · 2025
    Article
  9. [Advances in the development of transient receptor potential melastatin 2 channel inhibitors].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2025
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. The role of TRPV4 in programmed cell deaths.Molecular biology reports · 2024
    Review
  17. Article
  18. Curcumin attenuates hydroxychloroquine-mediated apoptosis and oxidative stress via the inhibition of TRPM2 channel signalling pathways in a retinal pigment epithelium cell line.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2023
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Mustafa NazıroğluDrug Discovery Unit, BSN Health, Analyses, Innovation, Consultancy, Organization, Agriculture and Trade Ltd, Isparta, TR-32260, Turkey. mustafanaziroglu@sdu.edu.tr.ORCID 0000-0003-0887-6974

Funding

BSN Health, Analyses, Innovation, Consultancy, Organization, Agriculture and Trade Ltd, Isparta, Turkey 2021-06
6 · The paper itself

Abstract

The overload cytosolic free Ca

Indexed as

AntioxidantsApoptosisCalciumCaspase 3Caspase 9CymenesHEK293 CellsHumansKidneyMembrane Potential, MitochondrialMicrogliaNeuronsOxidative StressReactive Oxygen SpeciesTRPM Cation ChannelsTRPV Cation ChannelsAntioxidantsCalciumcarvacrolCASP3 protein, humanCASP9 protein, humanCaspase 3Caspase 9CymenesReactive Oxygen SpeciesTRPM2 protein, humanTRPM Cation ChannelsTRPV4 protein, humanTRPV Cation ChannelsCarvacrolGlutathioneNeurodegenerationOxidative stressTRPM2TRPV4

Identifiers

PMID34989943
PMCPMC8732973

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.